Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not?
about
Dermatofibrosarcoma protuberans: Our experience of 59 casesEndometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors.Dermatofibrosarcoma protuberans in a 10-year-old childCurrent Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists.
P2860
Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Status report on the managemen ...... elpful and in which cases not?
@en
Status report on the managemen ...... elpful and in which cases not?
@nl
type
label
Status report on the managemen ...... elpful and in which cases not?
@en
Status report on the managemen ...... elpful and in which cases not?
@nl
prefLabel
Status report on the managemen ...... elpful and in which cases not?
@en
Status report on the managemen ...... elpful and in which cases not?
@nl
P2860
P1476
Status report on the managemen ...... elpful and in which cases not?
@en
P2093
Grace K Kim
P2860
P577
2011-03-01T00:00:00Z